Clinical Trials Logo

Clinical Trial Summary

The study evaluates the effects of a supervised exercise program on the physical performance, the mood and the complications of therapy in patients undergoing a high-dose chemotherapy followed by an autologous peripheral blood stem cell transplantation.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


NCT number NCT00883961
Study type Interventional
Source Charite University, Berlin, Germany
Contact Fernando Dimeo, MD
Phone +493084452098
Email fernando.dimeo@charite.de
Status Recruiting
Phase Phase 3
Start date December 2009
Completion date September 2011

See also
  Status Clinical Trial Phase
Completed NCT02660281 - URMC Related Haplo-identical Donor BMT Phase 1
Completed NCT03004261 - CMV-CTL for the Treatment of CMV Infection After HSCT Phase 4
Recruiting NCT01684189 - Registry of Febrile Neutropenia and Invasive Fungal Infections N/A
Completed NCT02447237 - Randomized Trial:the Effect of Liquid Food on the Intake of Energy and Protein in Malignant Hematologic Patients N/A
Not yet recruiting NCT06143098 - Some Hematological Profile in Children With Chronic Kidney Disease
Recruiting NCT04976205 - AI Algorithms to Automate the TMI by VMAT Optimization Using WB-CT/MRI and Synthetic WB-CT - The AuToMI Project N/A
Not yet recruiting NCT06050798 - Hematological Disorder in Patients With Angiodysplasia
Active, not recruiting NCT02158858 - A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis Phase 1/Phase 2
Enrolling by invitation NCT02456818 - Assessing the Effect of Contact Isolation on Nosocomial Colonization With ESBL-EC in German Hematology/Oncology Wards N/A
Recruiting NCT05727917 - Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation N/A
Completed NCT03355742 - XIENCE 28 Global Study N/A
Completed NCT00820508 - Safety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid Malignancies Phase 1
Terminated NCT01359254 - Cord Blood Transplantation for Patients With Cancer Phase 2